Company No:
Contents
| DIRECTOR | Jonathan Bernard Swift |
| REGISTERED OFFICE | 1 Fore Street Avenue |
| C/O Praxis | |
| London | |
| EC2Y 9DT | |
| United Kingdom |
| COMPANY NUMBER | 05760159 (England and Wales) |
| ACCOUNTANT | Praxis |
| 1 Fore Street Avenue | |
| London | |
| EC2Y 9DT | |
| United Kingdom |
| Note | 2026 | 2025 | ||
| £ | £ | |||
| Fixed assets | ||||
| Tangible assets | 4 |
|
|
|
| 2,787 | 1,136 | |||
| Current assets | ||||
| Debtors | 5 |
|
|
|
| Cash at bank and in hand |
|
|
||
| 4,880 | 4,972 | |||
| Creditors: amounts falling due within one year | 6 | (
|
(
|
|
| Net current liabilities | (27,998) | (28,595) | ||
| Total assets less current liabilities | (25,211) | (27,459) | ||
| Net liabilities | (
|
(
|
||
| Capital and reserves | ||||
| Called-up share capital | 7 |
|
|
|
| Profit and loss account | (
|
(
|
||
| Total shareholder's deficit | (
|
(
|
Director's responsibilities:
The financial statements of Touguise Limited (registered number:
|
Jonathan Bernard Swift
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
Touguise Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1 Fore Street Avenue, C/O Praxis, London, EC2Y 9DT, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director notes that the business has net liabilities of £25,211. The Company is supported through loans from the director. The director has confirmed that the loan facilities will continue to be available for at least 12 months from the date of signing these financial statements and the director will continue to support the Company. Given the current position, the director believes that any foreseeable debts can be met for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
| Goodwill |
|
| Plant and machinery etc. |
|
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
Financial assets
Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.
For financial assets carried at amortised cost, the amount of impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.
For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.
Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.
| 2026 | 2025 | ||
| Number | Number | ||
| Monthly average number of persons employed by the Company during the year, including the director |
|
|
| Goodwill | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 April 2025 |
|
|
|
| At 31 March 2026 |
|
|
|
| Accumulated amortisation | |||
| At 01 April 2025 |
|
|
|
| At 31 March 2026 |
|
|
|
| Net book value | |||
| At 31 March 2026 |
|
|
|
| At 31 March 2025 |
|
|
| Plant and machinery etc. | Total | ||
| £ | £ | ||
| Cost | |||
| At 01 April 2025 |
|
|
|
| Additions |
|
|
|
| At 31 March 2026 |
|
|
|
| Accumulated depreciation | |||
| At 01 April 2025 |
|
|
|
| Charge for the financial year |
|
|
|
| At 31 March 2026 |
|
|
|
| Net book value | |||
| At 31 March 2026 | 2,787 | 2,787 | |
| At 31 March 2025 | 1,136 | 1,136 |
| 2026 | 2025 | ||
| £ | £ | ||
| Corporation tax |
|
|
| 2026 | 2025 | ||
| £ | £ | ||
| Trade creditors |
|
|
|
| Taxation and social security |
|
|
|
| Other creditors |
|
|
|
|
|
|
There are no amounts included above in respect of which any security has been given by the small entity.
Included in other creditors is £31,289 (2025: £31,220) owed to the Director. Amounts owed to are repayable on demand and do not bear interest.
| 2026 | 2025 | ||
| £ | £ | ||
| Allotted, called-up and fully-paid | |||
|
|
|
|
The Company had no material capital commitments at the year ended 31 March 2026.